Walgreens reported strong Q4 earnings, exceeding expectations and leading to a surge in stock price.

From Barchart: 2025-01-10 07:14:21

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q4 CY2024 revenue of $39.46 billion, beating analyst estimates by 5.5%. Non-GAAP profit was $0.51 per share, 35.1% above consensus. Full-year adjusted EPS guidance is $1.60, surpassing expectations by 4.7%. Despite a 7.5% revenue growth, analysts project flat revenue in the next 12 months. Walgreens benefits from economies of scale but faces challenges in driving demand. Same-store sales grew by an average of 5.8% over the past two years. The stock price rose 8.7% post-earnings, but long-term investment decisions should consider business quality and valuation.



Read more at Barchart: Walgreens (NASDAQ:WBA) Reports Upbeat Q4, Stock Soars